Table 1 General characteristics of... | American Society of Hematology

Table 1

General characteristics of patients (N = 174)

Characteristics	Sex (M/F)	Age, y (S_E)	No. (%)	IPSS, mean
WHO classification
MDS, n = 94
Low grade, n = 66
RA/RCMD (20)	14/6	57 ± 15	11.5	0.55^Ψ
RARS/RCMD-RS (29)	20/9	69 ± 11	16.7	0.55
5q- syndrome (2)	0/2	70 ± 16	1.1	0
MDS-U (15)	9/6	71 ± 8	8.6	0.63^Ψ
Advanced grade, n = 28: RAEB1/2	16/13	62 ± 14	16.1	1.66
MDS/MPD, n = 47
RARS-T (11)	5/6	70 ± 7	6.3	0.05
MDS/MPD-U (12)	7/5	67 ± 7	6.9	0.5
CMML1/2 (24)	16/8	66 ± 9	13.8	0.94
sAML^†, n = 33	17/16	68 ± 11	19	2.75*
Controls, n = 76	32/44	44 ± 19	—	—

Characteristics	Sex (M/F)	Age, y (S_E)	No. (%)	IPSS, mean
WHO classification
MDS, n = 94
Low grade, n = 66
RA/RCMD (20)	14/6	57 ± 15	11.5	0.55^Ψ
RARS/RCMD-RS (29)	20/9	69 ± 11	16.7	0.55
5q- syndrome (2)	0/2	70 ± 16	1.1	0
MDS-U (15)	9/6	71 ± 8	8.6	0.63^Ψ
Advanced grade, n = 28: RAEB1/2	16/13	62 ± 14	16.1	1.66
MDS/MPD, n = 47
RARS-T (11)	5/6	70 ± 7	6.3	0.05
MDS/MPD-U (12)	7/5	67 ± 7	6.9	0.5
CMML1/2 (24)	16/8	66 ± 9	13.8	0.94
sAML^†, n = 33	17/16	68 ± 11	19	2.75*
Controls, n = 76	32/44	44 ± 19	—	—

— indicates not applicable.

RAEB-T (FAB) accounts for 15 of 33 secondary AML (WHO).

Has patients that cannot be analyzed for IPSS.

Only patients with sAML who fulfilled FAB criteria for RAEB-T were included in IPSS analysis.